AR and neoplasm: Numerous studies have identified mechanisms of castration resistance, including tumor cell‐intrinsic ones, such as androgen receptor (AR) amplifications and mutations, as well as microenvironmental ones, such as the enrichment of immunosuppressive myeloid‐derived suppressor cells (MDSCs) (Rebello et al, 2021).